Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Evonik Industries AG    EVK   DE000EVNK013

EVONIK INDUSTRIES AG

(EVK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Evonik Industries : Unilever accredits its collaboration with Evonik as one key pillar of its “Clean Future” initiative

share with twitter share with LinkedIn share with facebook
09/03/2020 | 11:29am EDT
  • As a biotechnology leader, Evonik is enabling Unilever to make its household cleaning products more sustainable
  • Evonik's green biosurfactants are fermentation-made, highly effective and 100% biodegradable
  • Collaboration underlines Evonik strategy to make sustainability a key driver of innovation and growth

Essen. Evonik, one of the world leaders in specialty chemicals and a market innovator for green biosurfactants used with household cleaning products, is proud to be enabling Unilever to achieve its goal of eliminating the use of fossil fuels in all of its cleaning brands by 2030.

Clean Future is a ground-breaking innovation program designed by Unilever's Home Care division that seeks to fundamentally change the way in which some of the world's best-known cleaning and laundry products are created, manufactured and packaged. Clean Future is unique in its intent to embed the principles of a circular economy into both packaging and product formulations at the commercial scale of global brands to eliminate or reduce their carbon footprint.

Yann d'Herve, Head of the Care Solutions business line at Evonik, said 'Evonik shares the ambition of Unilever to leverage advanced biomaterials and manufacturing processes such as fermentation to help realize the United Nations Sustainable Development Goals. We are proud to be investing and collaborating long term with partners such as Unilever who share similar sustainability goals.'

In its announcement, Unilever accredited its collaboration with Evonik, a 'biotechnology leader', as one key pillar of its Clean Future initiative.

Under a collaboration announced in December last year, Evonik is commercializing its innovative class of green biosurfactants known as rhamnolipids for use with a range of Unilever's household cleaning products. Evonik's rhamnolipids, which are sustainably manufactured via fermentation processes, can generate exceptional foam-forming properties and cleaning outcomes for household cleaning products while being 100% biodegradable. The capability to produce this naturally occurring class of biosurfactants on an industrial scale was achieved through a long-term R&D project between Creavis, the strategic innovation unit of Evonik, and Nutrition & Care.

Dr. Hans Henning Wenk, Vice President R&D Care Solutions, said 'We will continue to expand our portfolio of biotechnology-derived ingredients to strengthen our position as a leading provider of sustainable solutions that excite consumers and our customers.'

The Nutrition & Care division is one of Evonik's three growth divisions and the home of the biotechnology excellence centre. The innovation power in Nutrition & Care stems from a clear focus on sustainability, which also drives its portfolio transformation.

In addition to ingredients used in household cleaning and cosmetic products, Evonik's Nutrition & Care division is utilizing fermentation technologies across a range of other high-growth markets including sustainable animal nutrition, medical devices, advanced food ingredients and pharmaceutical drug products. Evonik is not only a biotechnology leader for the development of green biosurfactants and other advanced biomaterials, it is also a world-leading contract manufacturer for the production of products via microbial fermentation.

Disclaimer

Evonik Industries AG published this content on 03 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 September 2020 14:29:00 UTC


share with twitter share with LinkedIn share with facebook
All news about EVONIK INDUSTRIES AG
10/21EVONIK INDUSTRIES : sells stake in Synoste to Globus Medical in successful ventu..
PU
10/19EVONIK : Independant Research gives a Buy rating
MD
10/19EVONIK : NorldLB reiterates its Neutral rating
MD
10/16EVONIK : UBS remains a Sell rating
MD
10/16EVONIK : DZ Bank keeps its Buy rating
MD
10/16EVONIK : Receives a Buy rating from JP Morgan
MD
10/15EVONIK : Goldman Sachs reaffirms its Buy rating
MD
10/15EVONIK : Bernstein gives a Buy rating
MD
10/15EVONIK : Baader Bank reiterates its Buy rating
MD
10/15EVONIK INDUSTRIES : delivers Q3 adjusted EBITDA of €519 million above market exp..
PU
More news
Financials
Sales 2020 12 245 M 14 475 M 14 475 M
Net income 2020 552 M 653 M 653 M
Net Debt 2020 3 206 M 3 790 M 3 790 M
P/E ratio 2020 18,4x
Yield 2020 5,24%
Capitalization 10 210 M 12 066 M 12 070 M
EV / Sales 2020 1,10x
EV / Sales 2021 1,06x
Nbr of Employees 32 621
Free-Float 41,1%
Chart EVONIK INDUSTRIES AG
Duration : Period :
Evonik Industries AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVONIK INDUSTRIES AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 26,84 €
Last Close Price 21,95 €
Spread / Highest target 50,3%
Spread / Average Target 22,3%
Spread / Lowest Target -4,33%
EPS Revisions
Managers
NameTitle
Christian Kullmann Chairman-Executive Board
Bernd Tönjes Chairman-Supervisory Board
Ute Wolf Chief Financial Officer
Andreas Fischer Chief Innovation Officer
Siegfried Luther Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
EVONIK INDUSTRIES AG-19.33%12 262
SHIN-ETSU CHEMICAL CO., LTD.21.31%57 307
BASF SE-22.39%56 829
DUPONT DE NEMOURS, INC.-6.82%43 898
ROYAL DSM N.V.21.71%28 362
FMC CORPORATION7.97%13 965